Rhonda Ragsdale
Nurse Practitioner · Kingsport, TNNPI 1821229915
Payments from drug & device makers
Across 572 payments — averaging $17.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Johnson & Johnson$648
- Gilead$570
- QOL Medical, LLC$536
- plus $4K from 28 others
What the payments were for
- Food & beverage$9,76497%
- Education$2743%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 117 | $1,899 |
| Takeda Pharmaceuticals U.S.A., Inc. | 71 | $1,270 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 92 | $1,176 |
| Johnson & Johnson | 20 | $648 |
| Gilead | 27 | $570 |
| QOL Medical, LLC | 26 | $536 |
| Ardelyx, Inc. | 29 | $428 |
| Sanofi | 20 | $375 |
| Pfizer | 11 | $296 |
| Aimmune Therapeutics, Inc. | 16 | $280 |
| Intercept Pharmaceuticals, Inc. | 14 | $270 |
| Madrigal Pharmaceuticals | 9 | $230 |
| Nestle Healthcare Nutrition Inc. | 13 | $223 |
| Regeneron Healthcare Solutions, Inc. | 10 | $209 |
| Celltrion USA Inc. | 11 | $199 |
| Bristol Myers Squibb | 13 | $188 |
| Phathom Pharmaceuticals, Inc. | 17 | $166 |
| Ferring Pharmaceuticals Inc. | 8 | $165 |
| Evoke Pharma, Inc. | 9 | $150 |
| Ironwood Pharmaceuticals, Inc | 9 | $147 |
| Merck | 6 | $122 |
| Janssen Scientific Affairs, LLC | 2 | $108 |
| Lilly USA, LLC | 4 | $75 |
| Braintree Laboratories, Inc. | 3 | $63 |
| Novo Nordisk | 3 | $60 |
| Fresenius Kabi USA, LLC | 2 | $36 |
| Ipsen Biopharmaceuticals, Inc | 2 | $30 |
| Biogen | 1 | $24 |
| Mirum Pharmaceuticals, Inc. | 1 | $21 |
| Exact Sciences | 1 | $20 |
| Redhill Biopharma Inc. | 1 | $17 |
| Sandoz | 1 | $17 |
| Intra-sana Laboratories | 1 | $14 |
| Echosens North America, Inc. | 2 | $10 |
How this compares
$10,038 in reported general payments places this provider in the 95th percentile of 2,662 nurse practitioner providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntyvioVedolizumab | 11 | $90,899 |
| LinzessLinaclotide | 34 | $35,177 |
| IbsrelaTenapanor Hcl | 12 | $20,828 |
| NexiumEsomeprazole Magnesium | 12 | $6,938 |
| Esomeprazole Magnesium | 28 | $6,647 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 38 | $6,398 |
| MovantikNaloxegol Oxalate | 13 | $5,246 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 68 | $4,679 |
| Dexlansoprazole DrDexlansoprazole | 24 | $4,590 |
| Pantoprazole Sodium | 172 | $2,703 |
| Sucralfate | 78 | $2,406 |
| Colestipol Hcl | 31 | $1,990 |
| Omeprazole | 132 | $1,668 |
| Dicyclomine Hcl | 69 | $1,563 |
| Ursodiol | 14 | $1,107 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Entyvio | $1,270 | $90,89911 claims |
| AbbVieLinzess | $1,899 | $35,17734 claims |
| Ardelyx, Inc.Ibsrela | $428 | $20,82812 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $165 | $6,39838 claims |
| Redhill Biopharma Inc.Movantik | $17 | $5,24613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,662 nurse practitioner providers in Tennessee.
Other nurse practitioner in Kingsport
- Cara StoutKingsport$71K
- Autumn HooverKingsport$13K
- Amy HatcherMurfreesboro$1.1M
- Karen RodenKnoxville$265K
- Susan UtleyNashville$194K
- Whitney EricksonMemphis$159K
- Erica HembreeKnoxville$125K
- Brooke FaughtNashville$89K
- Lauren WelchNashville$71K
- S Marie HamiltonOoltewah$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.